- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Siemens' SieScape technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique that allows real-timeimaging of extremely large fields-of-view (SCAN 12/13/95).
With SieScape, a technologist can capture continuous acquisitionscovering nearly unlimited sweeps across the patient's body. Thedisplay pans across the acquisition at standard frame rates andmay be frozen over specific areas of interest. SieScape received510(k) clearance in October.
Also look for Siemens to discuss its Managed Healthcare Servicesdivision, which was formed earlier this year to offer businessconsulting services to radiology departments and hospitals (SCAN5/8/96).
In nuclear medicine, the variable-angle dual-head E.Cam willreprise the starring role it held at the Society of Nuclear Medicinemeeting in June (SCAN 6/5/96). Siemens will emphasize high-energytechniques for the system and plans to begin commercial shipmentsin November.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
